The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Declining Artesunate-Mefloquine Efficacy against Falciparum Malaria on the Cambodia–Thailand Border
Open accessAbstract
Resistance to many antimalaria drugs developed on the Cambodia-Thailand border long before developing elsewhere. Because antimalaria resistance is now a global problem, artemisinin-based combination therapies (ACTs) are the first-line therapies in most malaria-endemic countries. However, recent clinical and molecular studies suggest the emergence of ACT-resistant Plasmodium falciparum infections in the Cambodia-Thailand border area, where standard ACT is artesunate and mefloquine. These ACT failures might be caused by high-level mefloquine resistance because mefloquine was used for monotherapy long before the introduction of ACT. This observation raises 2 questions. First, how can existing P. falciparum-resistant strains be controlled? Second, how can the evolution of new ACT- resistant strains be avoided elsewhere, e.g., in Africa? Enforcement of rational drug use and improved diagnostic capacity are among the measures needed to avoid and contain ACT resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum
Reed, M. B., Saliba, K. J., Caruana, S. R., Kirk, K., & Cowman, A. F. (2000) · Nature · doi:10.1038/35002615 · Cited by 866
Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number
Price, R. N., Uhlemann, A.-C., Brockman, A., McGready, R., Ashley, E., Phaipun, L., Patel, R., Laing, K., Looareesuwan, S., White, N. J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16767-6 · Cited by 853
Thiers, B. H. (2006) · Yearbook of Dermatology and Dermatologic Surgery · doi:10.1016/s0093-3619(08)70110-2 · Cited by 512
Sidhu, A. B. S., Uhlemann, A., Valderramos, S. G., Valderramos, J., Krishna, S., & Fidock, D. A. (2006) · The Journal of Infectious Diseases · doi:10.1086/507115 · Cited by 415
Variations in frequencies of drug resistance in Plasmodium falciparum
Rathod, P. K., McErlean, T., & Lee, P.-C. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.17.9389 · Cited by 250
Snounou, G., & Beck, H.-P. (1998) · Parasitology Today · doi:10.1016/s0169-4758(98)01340-4 · Cited by 215
ALKER, A. P., LIM, P., SEM, R., SHAH, N. K., YI, P., BOUTH, D. M., TSUYUOKA, R., MAGUIRE, J. D., FANDEUR, T., ARIEY, F., et al. (2007) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2007.76.641 · Cited by 196
Self-citationCombination therapy for malaria in Africa: hype or hope?
Bloland, P. B., Ettling, M., & Meek, S. R. (2000) · PubMed · doi:10.1590/s0042-96862000001200005 · Cited by 172
Denis, M. B., Tsuyuoka, R., Yi, P., Narann, T. S., Suon, S., Lim, C., Incardona, S., Lim, P., Sem, R., Socheat, D., et al. (2006) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2006.01690.x · Cited by 138
Vijaykadga, S., Rojanawatsirivej, C., Cholpol, S., Phoungmanee, D., Nakavej, A., & Wongsrichanalai, C. (2006) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2005.01557.x · Cited by 115
Self-citationCoartem (Artemether‐Lumefantrine) in Africa: The Beginning of the End?
Hastings, I. M., & Ward, S. A. (2005) · The Journal of Infectious Diseases · doi:10.1086/432554 · Cited by 71
Mefloquine--its 20 years in the Thai Malaria Control Program.
Wongsrichanalai, C., Prajakwong, S., Meshnick, S. R., Shanks, G. D., & Thimasarn, K. (2004) · PubMed · Cited by 32
Self-citationAntimalarial drug combination policy: a caveat
Wongsrichanalai, C., Thimasarn, K., & Sirichaisinthop, J. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02416-8 · Cited by 28
Self-citation
Cited by
Artemisinin Resistance in Plasmodium falciparum Malaria
Dondorp, A. M., Nosten, F., Yi, P., Das, D., Phyo, A. P., Tarning, J., Lwin, K. M., Ariey, F., Hanpithakpong, W., Lee, S. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808859 · Cited by 3,424
Artemisinin resistance: current status and scenarios for containment
Dondorp, A. M., Yeung, S., White, L., Nguon, C., Day, N. P. J., Socheat, D., & von Seidlein, L. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2331 · Cited by 645
Chemical genetics of Plasmodium falciparum
Guiguemde, W. A., Shelat, A. A., Bouck, D., Duffy, S., Crowther, G. J., Davis, P. H., Smithson, D. C., Connelly, M., Clark, J., Zhu, F., et al. (2010) · Nature · doi:10.1038/nature09099 · Cited by 566
Discovery, mechanisms of action and combination therapy of artemisinin
Cui, L., & Su, X.-Z. (2009) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.09.68 · Cited by 371
Antimalarial Drug Resistance: Literature Review and Activities and Findings of the ICEMR Network
Cui, L., Mharakurwa, S., Ndiaye, D., Rathod, P. K., & Rosenthal, P. J. (2015) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.15-0007 · Cited by 305
Metadata
- Authors
- Wongsrichanalai, C., & Meshnick, S. R.
- Venue
- Emerging Infectious Diseases
- Published
- 2008-05
- Volume
- 14
- Issue
- 5
- Pages
- 716-719
- ISSN
- 1080-6040 (ISSN-L)
- 1080-6059
- OpenAlex
- W1990296740
- Cited by
- 309
- References
- 13
- FWCI
- 28.52
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.